|Articles|February 2, 2017
PAREXEL Acquires The Medical Affairs Company
PAREXEL has announced the acquisition of The Medical Affairs Company, a provider of outsourced medical affairs services to the pharma, biotech and medical device industries.
Advertisement
PAREXEL has announced the acquisition of The Medical Affairs Company, a provider of outsourced medical affairs services to the pharma, biotech and medical device industries. This acquisition provides an opportunity to reduce fixed costs for the pharma industry to address the growing commercialization-outsourcing market.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Breaking the Efficacy Ceiling in IBD and Beyond
3
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
4
ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program
5